- Home
- Publications
- Publication Search
- Publication Details
Title
Canakinumab investigated for treating familial Mediterranean fever
Authors
Keywords
-
Journal
EXPERT OPINION ON BIOLOGICAL THERAPY
Volume 16, Issue 11, Pages 1425-1434
Publisher
Informa UK Limited
Online
2016-09-11
DOI
10.1080/14712598.2016.1233963
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF)
- (2016) Erkan Demirkaya et al. ANNALS OF THE RHEUMATIC DISEASES
- Anakinra induce la remisión completa del síndrome nefrótico en un paciente con fiebre mediterránea familiar y amiloidosis
- (2016) Ángel M. Sevillano et al. NEFROLOGIA
- Brief Report: Severe Inflammation Following Vaccination AgainstStreptococcus pneumoniaein Patients With Cryopyrin-Associated Periodic Syndromes
- (2016) Ulrich A. Walker et al. Arthritis & Rheumatology
- Colchicine: Old and New
- (2015) Anastasia Slobodnick et al. AMERICAN JOURNAL OF MEDICINE
- Colchicine, Biologic Agents and More for the Treatment of Familial Mediterranean Fever. The Old, the New, and the Rare
- (2015) P. Portincasa CURRENT MEDICINAL CHEMISTRY
- Tolerance and efficacy of off-label anti-interleukin-1 treatments in France: a nationwide survey
- (2015) Linda Rossi-Semerano et al. Orphanet Journal of Rare Diseases
- Efficacy and safety of treatments in Familial Mediterranean fever: a systematic review
- (2015) Erkan Demirkaya et al. RHEUMATOLOGY INTERNATIONAL
- Treatment of colchicine-resistant Familial Mediterranean fever in children and adolescents
- (2015) Fehime Kara Eroglu et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy and safety of canakinumab in adolescents and adults with colchicine-resistant familial Mediterranean fever
- (2015) Ahmet Gül et al. ARTHRITIS RESEARCH & THERAPY
- Canakinumab as rescue therapy in familial Mediterranean fever refractory to conventional treatment
- (2015) Dario Roccatello et al. Drug Design Development and Therapy
- Anti-IL-1 treatment in familial Mediterranean fever and related amyloidosis
- (2014) Z. Birsin Özçakar et al. CLINICAL RHEUMATOLOGY
- Efficacy of Interleukin-1 Targeting Treatments in Patients with Familial Mediterranean Fever
- (2014) Pinar Cetin et al. INFLAMMATION
- Interleukin-1 targeting treatment in familial Mediterranean fever: an experience of pediatric patients
- (2014) Özge Başaran et al. Modern Rheumatology
- Rapid resolution of protracted febrile myalgia syndrome with anakinra: Report of two cases
- (2014) Rıdvan Mercan et al. Modern Rheumatology
- The Effect of Rilonacept versus Placebo on Health-Related Quality of Life in Patients with Poorly Controlled Familial Mediterranean Fever
- (2014) Philip J. Hashkes et al. Biomed Research International
- Canakinumab for the Treatment of Children With Colchicine-Resistant Familial Mediterranean Fever: A 6-Month Open-Label, Single-Arm Pilot Study
- (2014) Riva Brik et al. Arthritis & Rheumatology
- A76: Long-Term Efficacy of Canakinumab in Childhood Colchicine Resistant Familial Mediterranean Fever
- (2014) Philip Hashkes et al. Arthritis & Rheumatology
- Rilonacept for Colchicine-Resistant or -Intolerant Familial Mediterranean Fever
- (2013) Philip J. Hashkes et al. ANNALS OF INTERNAL MEDICINE
- Myositis in a patient with familial Mediterranean fever and spondyloarthritis successfully treated with anakinra
- (2013) Charline Estublier et al. JOINT BONE SPINE
- Treatment of autoinflammatory diseases: results from the Eurofever Registry and a literature review
- (2012) Nienke ter Haar et al. ANNALS OF THE RHEUMATIC DISEASES
- Effects of Anti-Tumor Necrosis Factor Agents for Familial Mediterranean Fever Patients With Chronic Arthritis and/or Sacroiliitis Who Were Resistant to Colchicine Treatment
- (2012) Sule Apras Bilgen et al. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
- The efficacy of canakinumab in the treatment of a patient with familial Mediterranean fever and longstanding destructive arthritis
- (2011) I. Mitroulis et al. ANNALS OF THE RHEUMATIC DISEASES
- Gain-of-Function Pyrin Mutations Induce NLRP3 Protein-Independent Interleukin-1β Activation and Severe Autoinflammation in Mice
- (2011) Jae Jin Chae et al. IMMUNITY
- Dramatic beneficial effect of interleukin-1 inhibitor treatment in patients with familial Mediterranean fever complicated with amyloidosis and renal failure
- (2011) K. Stankovic Stojanovic et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Synoviocyte innate immune responses: TANK-binding kinase-1 as a potential therapeutic target in rheumatoid arthritis
- (2011) D. Hammaker et al. RHEUMATOLOGY
- Interleukin-1 Targeting Drugs in Familial Mediterranean Fever: A Case Series and a Review of the Literature
- (2011) Ulrich Meinzer et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Anti-Interleukin 1 Treatment for Patients with Familial Mediterranean Fever Resistant to Colchicine: Table 1.
- (2010) SEZA ÖZEN et al. JOURNAL OF RHEUMATOLOGY
- Pneumonia in a patient with familial Mediterranean fever successfully treated with anakinra—case report and review
- (2010) Stefanie Hennig et al. RHEUMATOLOGY INTERNATIONAL
- Efficacy of anakinra treatment in a patient with colchicine-resistant familial Mediterranean fever
- (2010) Nilüfer Alpay et al. RHEUMATOLOGY INTERNATIONAL
- Familial Mediterranean Fever in the World
- (2009) Eldad Ben-Chetrit et al. ARTHRITIS AND RHEUMATISM
- Anti-IL-1 treatment for secondary amyloidosis in an adolescent with FMF and Behçet’s disease
- (2009) Yelda Bilginer et al. CLINICAL RHEUMATOLOGY
- A new set of criteria for the diagnosis of familial Mediterranean fever in childhood
- (2009) Fatoş Yalçınkaya et al. RHEUMATOLOGY
- Anakinra: New therapeutic approach in children with Familial Mediterranean Fever resistant to colchicine
- (2008) Rosa Roldan et al. JOINT BONE SPINE
- Successful treatment of familial Mediterranean fever with Anakinra and outcome after renal transplantation
- (2008) C. Moser et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started